Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,983,923
  • Shares Outstanding, K 128,396
  • Annual Sales, $ 50,120 K
  • Annual Income, $ -102,680 K
  • 60-Month Beta 0.48
  • Price/Sales 60.23
  • Price/Cash Flow N/A
  • Price/Book 6.77
Trade AUPH with:

Options Overview Details

View History
  • Implied Volatility 113.25%
  • Historical Volatility 63.82%
  • IV Percentile 72%
  • IV Rank 38.94%
  • IV High 199.93% on 01/15/21
  • IV Low 57.96% on 04/22/21
  • Put/Call Vol Ratio 0.64
  • Today's Volume 9,111
  • Volume Avg (30-Day) 16,307
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 211,993
  • Open Int (30-Day) 211,928

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.31
  • Number of Estimates 4
  • High Estimate -0.30
  • Low Estimate -0.33
  • Prior Year -0.28
  • Growth Rate Est. (year over year) -10.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.14 +45.91%
on 08/31/21
24.18 -2.61%
on 09/21/21
+5.85 (+33.05%)
since 08/27/21
3-Month
10.77 +118.66%
on 07/19/21
24.18 -2.61%
on 09/21/21
+9.25 (+64.69%)
since 06/25/21
52-Week
9.72 +142.28%
on 05/11/21
24.18 -2.61%
on 09/21/21
+9.30 (+65.26%)
since 09/25/20

Most Recent Stories

More News
Implied Volatility Surging for Aurinia (AUPH) Stock Options

Investors need to pay close attention to Aurinia (AUPH) stock based on the movements in the options market lately.

AUPH : 23.55 (+1.33%)
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the "Company") today announced that members of the senior management team will present at the following upcoming virtual investor conferences:

AUPH : 23.55 (+1.33%)
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the "Company") today announced that members of the senior management team will participate in the H.C. Wainwright & Co. 23rd Annual Global Investment Conference,...

AUPH : 23.55 (+1.33%)
Aurinia (AUPH) Adds Two Candidates, Boosts Immunology Pipeline

Aurinia (AUPH) acquires two pre-clinical, novel pipeline programs for the treatment of rare autoimmune, fibrotic and kidney diseases. Yet, the stock price declines.

VRTX : 183.41 (-0.11%)
MRNA : 408.84 (-4.95%)
RGEN : 307.37 (-4.92%)
AUPH : 23.55 (+1.33%)
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.

AUPH : 23.55 (+1.33%)
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

--- IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 2022/2023 -

AUPH : 23.55 (+1.33%)
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the "Company") today announced that members of the executive management team will participate in a fireside chat during the Virtual BTIG Annual Biotech Conference...

AUPH : 23.55 (+1.33%)
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates

Aurinia (AUPH) delivered earnings and revenue surprises of -5.71% and 32.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AUPH : 23.55 (+1.33%)
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ("Aurinia" or the "Company") today issued its financial results for the second quarter ended June 30, 2021. Amounts, unless specified otherwise, are expressed...

AUPH : 23.55 (+1.33%)
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021, after the markets close....

AUPH : 23.55 (+1.33%)
AUP.TO : 16.76 (-3.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Key Turning Points

3rd Resistance Point 24.75
2nd Resistance Point 24.27
1st Resistance Point 23.91
Last Price 23.55
1st Support Level 23.07
2nd Support Level 22.59
3rd Support Level 22.23

See More

52-Week High 24.18
Last Price 23.55
Fibonacci 61.8% 18.66
Fibonacci 50% 16.95
Fibonacci 38.2% 15.24
52-Week Low 9.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar